Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Differential expression of coagulation and inflammation genes in ITP patients before and after treatment with thrombopoietin receptor agonists

View Full Paper
Ask AI
Bookmark
Share

Authors

LGLamya GarabetAEAnna Eriksson

Discussion

Loading...

Member takes

Overview

Observational analysis reveals inflammation and coagulation gene expression changes in ITP patients, indicating a shift towards a procoagulant state post-treatment.

Key Points

  • Differential gene expression analysis showed significant changes in coagulation and inflammation genes after TPO-RA treatment in ITP patients.
  • Before treatment, upregulation of certain genes indicated increased inflammation and potential hemorrhage risks in ITP individuals.
  • Utilizing gene expression profiling, the study observed shifts in immune responses and hemostatic dysregulations in response to TPO-RA therapy.
  • Findings suggest that TPO-RA treatment may improve platelet counts while also increasing thrombotic risk due to a procoagulant environment.

Cite This Study

Garabet et al. (2025) studied this question.

synapsesocial.com/papers/69362f694fa91c937236df1dhttps://doi.org/10.1182/blood-2025-3018
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Transcriptomic characterization of platelets in immune thrombocytopenia indicates sustained activation and mitochondrial dysfunction2025
  2. 2Metabolic reprogramming of megakaryocyte subpopulations in ITP: Implications for TSPO in predicting response to TPO-RA2025 · 1 citations
  3. 3Platelet dysfunction in immune thrombocytopenia: finding clinical subsets with platelet phenotypes2025
  4. 4Thrombotic risk with thrombopoietin receptor agonists in immune thrombocytopenia: Real-world evidence from a multicenter Japanese study.2025
  5. 5Platelet functional activity in patients with immune thrombocytopenia2025